PGPeter Gates

Peter Gates

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Gates has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A systematic review and meta-analysis of comprehensive community initiatives on tobacco use and related harms

    by Peter Gates, Emily Deans, Andrea Zocco, Iona McClean, Thomas Santo, Sara Farnbach

  • Open Access

    Systematic review and meta analysis of comprehensive community initiatives on alcohol use and related harms

    by Peter Gates, Emily Deans, Thomas Santo, Sara Farnbach

    Background and aims: Comprehensive community initiatives (CCI) are prioritised in global drug strategies to address alcohol related harms. However, their impact is unclear and moderators of impact are rarely considered. We explored CCIs that address alcohol use or related harms including approaches, effectiveness and factors that strengthen impact. Method: A systematic review and meta‐analysis (PROSPERO ID CRD420251044005). Embase, Medline, CINAHL, PsycINFO and the Cochrane Database of Systematic Reviews were searched. Reference lists for English‐language articles were hand‐searched without date restriction. A meta‐analysis and qualitative synthesis were completed on any measure of alcohol use or related harms including potential moderators of impact (including community type, level of engagement, initiative combinations, duration, recency, evaluation quality and length of follow‐up). Results: The systematic review included 44 studies (from 15 419 articles), with 35 assessing alcohol use and 21 assessing alcohol‐related harms. Meta analysis included 15 outcome estimates from nine studies across three alcohol use outcomes: any recent (past month) alcohol use [six studies, n = 32 397, relative risk (RR) = 0.96, 95% confidence interval (CI) = 0.87–1.06, heterogeneity ( I 2 ) = 85.6%], any lifetime alcohol use (three studies, n = 13 025, RR = 0.82, 95% CI = 0.63–1.08, I 2 = 96.8%) and any recent risky drinking (six studies, n = 82 383, RR = 1.02, 95% CI = 0.95–1.10, I 2 = 72.9%). Data were insufficient for meta‐analysis of additional alcohol use (e.g. frequency) or related harms outcomes. Subgroup analyses were underpowered and did not identify clear moderators of impact. Pooled estimates were imprecise, with substantial‐to‐considerable heterogeneity across outcomes ( I 2 = 72.9%–96.8%; τ 2 = 0.0049–0.0544) and findings varied across studies. CCIs showed possible small preventive effects on any alcohol use, but not on recent risky drinking. Qualitative analysis indicated that CCIs incorporating school‐based or parenting components showed more consistent signals of benefit compared with other initiative combinations. Conclusions: Conclusions on the impact of comprehensive community initiatives on alcohol use and harms remain tentative because estimates from existing studies are imprecise and findings vary across studies.

  • Open Access

    Definitions of community‐level approaches to address substance‐related harms and lessons learned: A systematic overview of reviews

    by Peter Gates, Andrea Zocco, Sara Farnbach

    Community action focused on sociocultural and environmental influences to prevent alcohol and other drug (AOD) use and related harms is a global priority. Despite this recognition, understanding of effective community‐level approaches is limited. This umbrella review aimed to develop a unifying term to define and describe community‐level AOD approaches and summarize lessons learned from implementation. We searched Embase/MEDLINE, PsycINFO, the Cochrane Database of Systematic Reviews, two online registries and reference lists of included studies. Eligible reviews focused on community‐level approaches addressing AOD use or harms. Two authors independently screened articles and completed full‐text review and data extraction. We identified 87 reviews, spanning three decades. We propose the term Comprehensive Community Initiatives (CCI) to define community‐level AOD approaches. CCIs involve multiple coordinated initiatives implemented across a community and are categorised into four types and eleven subtypes. School‐based activities, the most common initiative subtype, were reported by reviews to be most effective when interactive and peer‐focused, while fear‐based approaches reportedly lack impact. Meaningful community engagement was central across recommendations to improve effectiveness. We summarize lessons learned for each initiative subtype, including recommendations, barriers, facilitators, and moderators of impact to guide future implementation.


  • Open Access

    Harm to Children from Prescribing and Administration Errors in Acute Care: A Multidisciplinary Panel Assessment

    by Virginia Mumford, Magdalena R. Raban, Erin Fitzpatrick, Amanda Woods, Alison Merchant, Tim Badgery-Parker, Ling Li, Peter Gates, Richard O. Day, Geoffrey Ambler, et al.

    Introduction Medication errors continue to cause inpatient harm in children and can be difficult to both identify and classify. Medication error studies often focus on assessing potential harm and there is little published data on actual harm from medication errors in children. Objective Our aim was to use multidisciplinary panels to identify and describe the actual harm resulting from prescribing and administration medication errors occurring at a major paediatric hospital. Methods We reviewed medication error data collected from retrospective medication record reviews to identify prescribing errors (26,369 orders, 19,692 errors and 3782 patients) and prospective direct observations (5137 dose administrations, 3663 errors and 1530 patients) to identify administration errors. Errors with the potential to cause serious harm and with evidence that the error reached the patient formed the dataset for our study. Case studies (n = 566) describing the prescribing and administration errors and a brief clinical summary were reviewed by multidisciplinary panels to determine whether there was evidence in patients’ records of actual harm and to rate the severity of the harm identified. Results Actual harm was identified in 89 case studies and rated as minor in 43% (n = 38), moderate in 48% (n = 43) and serious in 9% (n = 8). There were no cases of harm rated as severe resulting in death. Antibacterials were the most common medications in cases with harm (n = 38/89 cases), and dosing errors (n = 32/89) the most common error type associated with harm. Younger patients had a significantly (t = 2.4, df = 198, p = 0.017) greater risk of actual harm from medication errors, and children aged under 12 months formed a higher proportion of those with actual harm (χ2 (1, N = 566) = 10.5, p = 0.001). The most frequent type of administration errors leading to harm were wrong infusion rates of intravenous antibiotics (19/67 cases); 12 of these instances occurred in children under 12 months. Administration errors were more likely to result in actual harm (1.83%; 67 /3663 errors) compared with prescribing errors (0.21%; 42/19,692). Conclusions We found higher rates of actual harm associated with medication errors in younger patients, wrong dose prescribing errors and intravenous antibiotic administration errors. These important findings provide opportunities for developing tailored interventions targeting identified high-risk areas to enable the successful reduction of preventable harms in paediatric patients.


  • Open Access

    A systematic review of reviews on comprehensive community initiatives to prevent or reduce alcohol and other drug harms

    by Peter John Gates, Andrea C. Zocco, Sara Farnbach

    Background and Aims: Comprehensive community initiatives (CCI) aimed at reducing or preventing alcohol or other drug (AOD) harms incorporate multiple initiatives delivered to whole communities to effect community‐level change on sociocultural and environmental factors. CCIs have gained in popularity and have been subject to extensive research; however, CCIs comprise multiple initiatives and evidence for effectiveness by substance type has been mixed. This umbrella review aimed to synthesise information from published reviews to describe the combination of CCIs with the most consistent evidence for impact for each substance type. Method: We searched Embase/Medline, PsycINFO, Cochrane Database of Systematic Reviews, two online registries and hand searched references for English language reviews without date restriction and conducted an umbrella review using mixed methods synthesis (PROSPERO CRD42023432567). We considered all types of reviews focused on CCIs and addressing AOD use or harms. Two reviewers independently screened all articles and conducted full text review. Extraction of main results relating to CCI impact and quality assessment using AMSTAR‐2 and SANRA was completed by two independent reviewers and corrected covered area analysis conducted. Results: We identified 87 reviews spanning three decades; 14 were rated high quality. Most reviews considered individual substances [alcohol (43 reviews) or tobacco (35 reviews) and rarely illicit drugs (16 reviews)], and some limited scope to ‘at‐risk’ community members [young people (26 reviews) and First Nations (8 reviews)]. Although the evidence did not meet criteria for consistent impact, communities should consider implementing school‐based (supported by 36 of 50 reviews) and parenting‐related (29 of 37 reviews) activities that are supported by media campaign where feasible (29 of 51 reviews). CCIs have the most consistent impact on alcohol (supported by 24 of 32 reviews) and tobacco‐related outcomes (22 of 35 reviews), though illicit drugs are yet to be adequately assessed. Conclusions: Although the available evidence regarding comprehensive community initiatives is largely inconsistent, the addition of parenting‐related activities to existing school‐based education campaigns is likely to improve effectiveness. A media campaign may extend their reach to those outside school settings. Future evaluation of CCIs should measure impact of activities in isolation where possible and incorporate process measures to gauge community engagement and empowerment.


  • Open Access

    A scoping review of program evaluations in non-profit alcohol and other drugs service settings: Considerations for service and research partnerships

    by Emily Deans, George Economidis, Peter Gates, Andrea Zocco, Robert Stirling, Sally Nathan, Suzie Hudson, Sara Farnbach


  • Open Access

    Understanding prescribing errors for system optimisation: the technology-related error mechanism classification

    by Magdalena Z Raban, Alison Merchant, Erin Fitzpatrick, Melissa T Baysari, Ling Li, Peter Gates, Johanna I Westbrook

    Objectives: Technology-related prescribing errors curtail the positive impacts of computerised provider order entry (CPOE) on medication safety. Understanding how technology-related errors (TREs) occur can inform CPOE optimisation. Previously, we developed a classification of the underlying mechanisms of TREs using prescribing error data from two adult hospitals. Our objective was to update the classification using paediatric prescribing error data and to assess the reliability with which reviewers could independently apply the classification. Materials and methods: Using data on 1696 prescribing errors identified by chart review in 2016 and 2017 at a tertiary paediatric hospital, we identified errors that were technology-related. These errors were investigated to classify their underlying mechanisms using our previously developed classification, and new categories were added based on the data. A two-step process was used to identify and classify TREs involving a review of the error in the CPOE and simulating the error in the CPOE testing environment. Results: The technology-related error mechanism (TREM) classification comprises six mechanism categories, one contributing factor and 19 subcategories. The categories are as follows: (1) incorrect system configuration or system malfunction, (2) opening or using the wrong patient record, (3) selection errors, (4) construction errors, (5) editing errors, (6) errors that occur when using workflows that differ from a paper-based system (7) contributing factor: use of hybrid systems. Conclusion: TREs remain a critical issue for CPOE. The updated TREM classification provides a systematic means of assessing and monitoring TREs to inform and prioritise system improvements and has now been updated for the paediatric setting.


  • Open Access

    Understanding technology-related prescribing errors for system optimisation: the Technology-Related Error Mechanism (TREM) classification

    by Magdalena Z. Raban, Alison Merchant, Erin Fitzpatrick, Melissa T. Baysari, Ling Li, Peter J. Gates, Johanna I. Westbrook

    Objectives Technology-related prescribing errors curtail the positive impacts of computerised provider order entry (CPOE) on medication safety. Understanding how technology-related errors occur can inform CPOE optimisation. Previously, we developed a classification of the underlying mechanisms of technology-related errors using prescribing error data from two adult hospitals. Our objective was to update the classification using paediatric prescribing error data, and to assess the reliability with which reviewers could independently apply the classification. Materials and Methods Using data on 1696 prescribing errors identified by chart review in 2016 and 2017 at a tertiary paediatric hospital, we identified errors that were technology-related. These errors were investigated to classify their underlying mechanisms using our previously developed classification, and new categories were added based on the data. A two-step process was used to identify and classify technology-related errors involving review of the error in the CPOE and simulating the error in the CPOE testing environment. Results The Technology-Related Error Mechanism (TREM) classification comprises seven categories and 19 subcategories. The seven categories are: 1) errors due to incorrect system configuration or system malfunction, 2) prescribing on the wrong patient record, 3) selection errors, 4) construction errors, 5) editing errors, 6) errors that occur when using workflows that differ from a paper-based system 7) contributing factor: use of hybrid systems. Conclusion Technology-related errors remain a critical issue for CPOE. The updated TREM classification provides a systematic means of assessing and monitoring technology-related errors to inform and prioritise system improvements, and has now been updated for the paediatric setting. What is already known on this topic Technology-related errors occur frequently in computerised provider order entry (CPOE). Technology-related errors can be addressed by CPOE modifications; however, an understanding of how the errors occurred is required. What this study adds This study presents a method for classifying how technology-related errors occur, the Technology-Related Error Mechanism (TREM) classification. How this study might affect research, practice or policy Using the TREM classification can aid system managers in identifying areas for CPOE optimisation to deliver improved patient safety outcomes.

  • Open Access

    Developing a process to measure actual harm from medication errors in paediatric inpatients: From design to implementation

    by Virginia Mumford, Magdalena Z. Raban, Ling Li, Erin Fitzpatrick, Amanda Woods, Alison Merchant, Tim Badgery‐Parker, Peter Gates, Melissa Baysari, Ric O. Day, et al.

    Aims: The potential harm associated with medication errors is widely reported, but data on actual harm are limited. When actual harm has been measured, assessment processes are often poorly described, limiting their ability to be reproduced by other studies. Our aim was to design and implement a new process to assess actual harm resulting from medication errors in paediatric inpatient care.Methods: Prescribing errors were identified through retrospective medical record reviews (n = 26 369 orders) and medication administration errors through direct observation (n = 5137 administrations) in a tertiary paediatric hospital. All errors were assigned potential harm severity ratings on a 5‐point scale. Multidisciplinary panels reviewed case studies for patients assigned the highest three potential severity ratings and determined the following: actual harm occurrence and severity level, plausibility of a link between the error(s) and identified harm(s) and a confidence rating if no harm had occurred.Results: Multidisciplinary harm panels (n = 28) reviewed 566 case studies (173 prescribing related and 393 administration related) and found evidence of actual harm in 89 (prescribing = 22, administration = 67). Eight cases of serious harm cases were found (prescribing = 1, administration = 7) and no cases of severe harm. The panels were very confident in 65% of cases (n = 302) where no harm was found. Potential and actual harm ratings varied.Conclusions: This harm assessment process provides a systematic method for determining actual harm from medication errors. The multidisciplinary nature of the panels was critical in evaluating specific clinical, therapeutic and contextual considerations including care delivery pathways, therapeutic dose ranges and drug–drug and drug–disease interactions.


  • Open Access

    Effectiveness of non-interruptive nudge interventions in electronic health records to improve the delivery of care in hospitals: a systematic review

    by Magdalena Z Raban, Peter J Gates, Sarah Gamboa, Gabriela Gonzalez, Johanna I Westbrook

    To describe the application of nudges within electronic health records (EHRs) and their effects on inpatient care delivery, and identify design features that support effective decision-making without the use of interruptive alerts. We searched Medline, Embase, and PsychInfo (in January 2022) for randomized controlled trials, interrupted time-series and before–after studies reporting effects of nudge interventions embedded in hospital EHRs to improve care. Nudge interventions were identified at full-text review, using a pre-existing classification. Interventions using interruptive alerts were excluded. Risk of bias was assessed using the ROBINS-I tool (Risk of Bias in Non-randomized Studies of Interventions) for non-randomized studies or the Cochrane Effective Practice and Organization of Care Group methodology for randomized trials. Study results were summarized narratively. We included 18 studies evaluating 24 EHR nudges. An improvement in care delivery was reported for 79.2% (n = 19; 95% CI, 59.5–90.8) of nudges. Nudges applied were from 5 of 9 possible nudge categories: change choice defaults (n = 9), make information visible (n = 6), change range or composition of options (n = 5), provide reminders (n = 2), and change option-related effort (n = 2). Only one study had a low risk of bias. Nudges targeted ordering of medications, laboratory tests, imaging, and appropriateness of care. Few studies evaluated long-term effects. Nudges in EHRs can improve care delivery. Future work could explore a wider range of nudges and evaluate long-term effects. Nudges can be implemented in EHRs to improve care delivery within current system capabilities; however, as with all digital interventions, careful consideration of the sociotechnical system is crucial to enhance their effectiveness.